DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies.
Andrea L. Reid, Yimin Wang, Adrienne Samani, Rylie M. Hightower, Michael A. Lopez, Shawn R. Gilbert, Lara Ianov, David K. Crossman, Louis J. Dell’Italia, Douglas P. Millay, Thomas van Groen, Ganesh V. Halade, Matthew S. Alexander
This study investigates the role of DOCK3 in skeletal muscle and Duchenne muscular dystrophy, finding that reducing DOCK3 improves dystrophic muscle histology while complete loss worsens muscle function.
Human Molecular Genetics · Jul 31, 2020Peer-reviewedGenetics